- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lunar revenues climb, but profit falls
Bone densitometry firm Lunar’s effort to grow revenues by targeting the physician office market is experiencing success. The Madison, WI, company enjoyed a 22% rise in revenues for its third quarter (end-September). Lower profit margins associated
Bone densitometry firm Lunars effort to grow revenues by targeting the physician office market is experiencing success. The Madison, WI, company enjoyed a 22% rise in revenues for its third quarter (end-September). Lower profit margins associated with the initiative resulted in declining net income for the firm, however.
For the quarter, Lunar recorded revenues of $22.8 million, compared with $18.7 million in the third quarter of 1997. Lunars net income for the third quarter of 1998 was $1.2 million, compared with $2 million in the third quarter of 1997. Lunars profit for the most recent quarter was also affected by a $580,000 charge for the settlement of patent litigation.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
